AbbVie Inc (BUE:ABBV)
ARS 21100 275 (1.32%) Market Cap: 326.28 Til Enterprise Value: 391.76 Til PE Ratio: 63.33 PB Ratio: 53.42 GF Score: 74/100

Abbvie Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 02:50PM GMT
Release Date Price: ARS8328
Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst

Great. Well, thanks for joining us, everybody. I'm Terence Flynn, the U.S. Biopharma Analyst here at Morgan Stanley. Very pleased to be hosting AbbVie this morning for the session. Today, joining us from the company, we have Rob Michael, President and COO; Scott Reents, who's CFO; Jeff Stewart, CCO; and Roopal Thakkar, who is Head of Development and Regulatory Affairs and CMO. But thank you so much all for being here. Really appreciate the time.

Robert A. Michael
AbbVie Inc. - President & COO

Thanks for having us.

Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst

Before we get started for disclosures, please see Morgan Stanley's research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. With that out of the way. Maybe Rob will go over

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot